MedPath

Effect analysis of the application of different doses of remimazolam besylate in painless gastroscopy

Not Applicable
Recruiting
Conditions
Painless gastrointestinal endoscopy
Registration Number
ChiCTR2400089070
Lead Sponsor
The First Affiliated Hospital of Xinjiang Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Age 18-65 years old, (2) Body mass index (BMI) < 28kg/?, (3) Acceptable for gastrointestinal endoscopy (4) United States Association of Anesthesiologists (ASA) classification I-III.

Exclusion Criteria

(1) Those who are allergic to benzodiazepines (2) Those who use analgesics and benzodiazepines for a long time (3) Those who have a history of major heart, lung, liver or kidney diseases and patients with myasthenia gravis (4) Those who have schizophrenia or severe depression (5) Those who have long-term alcohol or drug abuse (6) Those who have a history of difficult tracheal intubation (7) Pregnant women

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean arterial pressure, MAP;Heart rate, HR;SpO2;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath